Lingotto
VC Fund
London, United Kingdom
Lingotto is an investment management company owned by Exor N.V. and launched by the Italian dynasty the Agnelli family. The company possesses a set of distinctive competitive edges that distinguish it in the market. One key strength lies in its unique investment strategies, which are complementary, differentiated, and unparalleled, providing a competitive advantage over its peers. Moreover, the company has fostered a culture of partnership, promoting autonomy and cooperation among its stakeholders. This collaborative approach not only enhances teamwork but also strengthens relationships within the organization. Another significant aspect of the company's operations is its unwavering commitment to accountability, integrity, and transparency, ensuring a high level of trust and reliability for its clients and partners.
- Total investments:
- 39
- Last investment:
- Lead investor:
- 26%
- Fund size:
- $301M
- Last fund:
Last updated:
For AI agents: llms.txt
Industries Lingotto invests in
Stages Lingotto invests in
Countries Lingotto invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Round size
- Series A
- $15M–$91M
- Series B
- $55M–$159M
Investment Focus
Industry
- Artificial Intelligence 8 (21%)
- Biotechnology 5 (13%)
- Robotics 4 (10%)
- Energy 3 (8%)
- Finance 3 (8%)
Stage
- Series A 8 (21%)
- Series B 4 (10%)
- Funding Round 4 (10%)
- Series C 3 (8%)
- Venture - Series Unknown 3 (8%)
Country
- United States 9 (23%)
- Germany 3 (8%)
- United Kingdom 3 (8%)
- India 2 (5%)
- Mexico 1 (3%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Morgan Samet
Managing Partner & Co-Head @ Lingotto Innovation
|
Managing Partner & Co-Head @ Lingotto Innovation | Total investments: 9 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Multiply Labs manufactures personalized pharmaceutical capsules that are tailor-made to the unique needs of each patient. Multiply Labs’ product is enabled by the combination of pharmaceutical science with robotics technology. The company has built and operates a unique robotic pharmaceutical manufacturing facility. Multiply Labs is the firstcompany ever to bring to the market 3D printed capsules. | $75M / Series B / Oct 06, 2026 | ||
| RobCo is a company that develops modular industrial robotics systems combined with AI-driven software to automate manual and repetitive tasks in manufacturing environments. It provides a platform that includes configurable robotic hardware, no-code programming tools, AI-powered vision systems, and digital simulation to plan, test, and deployautomation workflows across applications like machine loading, palletizing, and materials handling. The company’s solutions are designed to be flexible and scalable so manufacturers can adapt robot configurations as production requirements evolve. RobCo also offers tools for remote management, predictive maintenance, and integration with existing equipment to support continuous operation. Its products aim to simplify the adoption of robotics by reducing the need for specialized programming and enabling simulation-based validation before physical deployment. | Secondary Market / Oct 05, 2026 | ||
| Andromeda Surgical is a developer of autonomous robots intended to make surgery more consistent, error-free, and efficient. | $15M / Series A / Aug 04, 2026 | ||
| NEURA Robotics is a high-tech robotics company which is poised to usher the way into the cognitive era by building intelligent robotic assistants which can be used in all areas of life. At NEURA Robotics, we bridge the gap of human-robot interaction by advancing robots’ cognitive abilities with groundbreaking leaps in environment perception,mechanical design, and artificial intelligence. We have successfully introduced the first-ever commercially available cognitive robot, MAiRA, together with MAV –the Multi-Sensing Autonomous Vehicle and LARA - the Lightweight Agile Robotic Assistant. By giving the robot what is currently missing: senses and a mind, we aim to not only revolutionize modern production sites but also conquer new markets such as medical technologies, home automation, food and agricultural production. | $1.4B / Series C / Jun 10, 2026 | ||
| Minerva uses advanced statistical modeling, artificial intelligence, and data science to create forecasts of income and assets. | $20M / Series A / Jun 09, 2026 | ||
| Salma Health is a concierge neurocognitive clinic that uses neurology and psychiatry techniques to solve various brain conditions. | $80M / Series A / Feb 26, 2026 | ||
| KAVAK is an online platform that offers insight into buying and selling used cars. It specializes in the fields of e-commerce, automotive, and retail. KAVAK e-commerce for the purchase and sale of pre-owned cars in Latin America. It was founded in 2016 and headquartered in Mexico City, Distrito. | $300M / Series F / Feb 17, 2026 | ||
| RobCo is a company that develops modular industrial robotics systems combined with AI-driven software to automate manual and repetitive tasks in manufacturing environments. It provides a platform that includes configurable robotic hardware, no-code programming tools, AI-powered vision systems, and digital simulation to plan, test, and deployautomation workflows across applications like machine loading, palletizing, and materials handling. The company’s solutions are designed to be flexible and scalable so manufacturers can adapt robot configurations as production requirements evolve. RobCo also offers tools for remote management, predictive maintenance, and integration with existing equipment to support continuous operation. Its products aim to simplify the adoption of robotics by reducing the need for specialized programming and enabling simulation-based validation before physical deployment. | $100M / Series C / Jan 29, 2026 | ||
| Optalysys solves the fundamental limitations of conventional computing. Optalysys develops optical AI systems that accelerate the demanding deep learning and pattern recognition tasks at groundbreaking speeds but at a fraction of the energy consumption of traditional computing hardware.Optalysys' embeddable technology will enablesupercomputing capability in Edge and mobile devices. | $30.9M / Series A / Jan 22, 2026 | ||
| Trade Republic is a mobile-only and commission-free broker that brings the opportunity to invest easily. The company works as a broker for a new generation for a more mobile, more intuitive, faster - and permanently free of commission. Trade Republic was founded in 2015 and based in Berlin, Germany. | $1.4B / Secondary Market / Dec 17, 2025 | ||
| See all 39 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Lingotto invest in?
Lingotto invests primarily in Artificial Intelligence, Biotechnology and Robotics startups, most often at Series A and Series B stage. Most of the 39 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What round sizes does Lingotto invest in?
Lingotto typically joins rounds of $15M–$91M at Series A and $55M–$159M at Series B. These are whole funding-round sizes, not Lingotto's own check, which is rarely disclosed: the 10th–90th percentile of the confirmed public funding rounds Lingotto took part in.
How do I contact Lingotto?
Public channels for Lingotto include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Lingotto?
The team at Lingotto includes Morgan Samet (Managing Partner & Co-Head @ Lingotto Innovation). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
